Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Guckenberger

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Radiation Oncology (London, England)|January 24, 2018
Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning studyL Basler, N Andratschke, S Ehrbar, et al.
Radiation Oncology (London, England)|December 4, 2016
SBRT for centrally localized NSCLC - What is too central?J Roesch, C Panje, F Sterzing, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2013
Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancerM Guckenberger, N Andratschke, H Alheit, et al.
BMC Cancer|April 8, 2018
Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapyT Finazzi, T Rordorf, K Ikenberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2020
Re-irradiation in the thorax - An analysis of efficacy and safety based on accumulated EQD2 dosesC Schröder, I Stiefel, S Tanadini-Lang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 14, 2025
Boosting the Evidence: Time to Integrate Simultaneous Integrated Boost in Spine Stereotactic Body Radiotherapy?C Udovicich, S Siva, J Palmer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 16, 2013
Studies on the role of osteopontin-1 in endometrial cancer cell linesJ C Hahne, S R Meyer, P Kranke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 29, 2012
Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancerM Guckenberger, G Saur, D Wehner, et al.
Clinical and Translational Radiation Oncology|March 4, 2021
High-dose re-irradiation of intracranial lesions - Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculationI Stiefel, C Schröder, S Tanadini-Lang, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 10, 2019
Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countriesS G C Kroeze, C Fritz, L Basler, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Radiation Oncology (London, England)|January 24, 2018
Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning studyL Basler, N Andratschke, S Ehrbar, et al.
Radiation Oncology (London, England)|December 4, 2016
SBRT for centrally localized NSCLC - What is too central?J Roesch, C Panje, F Sterzing, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 21, 2013
Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancerM Guckenberger, N Andratschke, H Alheit, et al.
BMC Cancer|April 8, 2018
Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapyT Finazzi, T Rordorf, K Ikenberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2020
Re-irradiation in the thorax - An analysis of efficacy and safety based on accumulated EQD2 dosesC Schröder, I Stiefel, S Tanadini-Lang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 14, 2025
Boosting the Evidence: Time to Integrate Simultaneous Integrated Boost in Spine Stereotactic Body Radiotherapy?C Udovicich, S Siva, J Palmer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 16, 2013
Studies on the role of osteopontin-1 in endometrial cancer cell linesJ C Hahne, S R Meyer, P Kranke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 29, 2012
Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancerM Guckenberger, G Saur, D Wehner, et al.
Clinical and Translational Radiation Oncology|March 4, 2021
High-dose re-irradiation of intracranial lesions - Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose EQD calculationI Stiefel, C Schröder, S Tanadini-Lang, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 10, 2019
Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countriesS G C Kroeze, C Fritz, L Basler, et al.
Pageof 7